GE HealthCare price target lowered to $65 from $80 at Citi

Citi lowered the firm’s price target on GE HealthCare (GEHC) to $65 from $80 and keeps a Neutral rating on the shares. Expectations were low going into the print, but “unfortunately,” GE HealthCare missed and lowered 2026 EPS guidance to $4.80-$5.00 from $4.95-$5.15 versus consensus at $5.06, the analyst tells investors. While the firm would “want to believe that this reset is enough,” it says GE HealthCare “has moved into the ‘show me’ camp.”